JMPWA
RDY icon

JP Morgan Private Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-57,230
Closed -$652K – 1822
2023
Q1 		$652K Buy
57,230
+26,280
+85% +$284K ﹤0.01% 1357
2022
Q4 		$320K Buy
+30,950
New +$334K ﹤0.01% 1631
2014
Q2 		– Sell
-22,875
Closed -$201K – 907
2014
Q1 		$201K Buy
+22,875
New +$199K ﹤0.01% 810

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Private Wealth Advisors's RDY Position: Q2 2023 in Review

JP Morgan Private Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2023, closing a stake of 57,230 shares — an estimated $652K sold.

JP Morgan Private Wealth Advisors first reported a position in RDY in Q1 2014 and held it in 3 quarters. The position peaked at $652K in Q1 2023. 194 funds tracked by Wall St. Rank hold RDY as of Q2 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 57,230 Dr. Reddy's Laboratories shares in Q2 2023, an estimated $652K.
  • JP Morgan Private Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's Dr. Reddy's Laboratories position peaked at $652K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.